210 related articles for article (PubMed ID: 35245520)
21. Curcumae longae Rhizoma (Jianghuang) extract reverses the 5-Fluoruracil resistance in colorectal cancer cells via TLR4/PI3K/Akt/mTOR pathway.
Teng Z; Sun X; Guo Y; Zhang M; Liu Y; Xu M
Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101976. PubMed ID: 35710041
[TBL] [Abstract][Full Text] [Related]
22. Anticancer activity of safranal against colon carcinoma is due to induction of apoptosis and G2/M cell cycle arrest mediated by suppression of mTOR/PI3K/Akt pathway.
Zhang Y; Zhao Y; Guo J; Cui H; Liu S
J BUON; 2018; 23(3):574-578. PubMed ID: 30003721
[TBL] [Abstract][Full Text] [Related]
23. Thymoquinone subdues tumor growth and potentiates the chemopreventive effect of 5-fluorouracil on the early stages of colorectal carcinogenesis in rats.
Kensara OA; El-Shemi AG; Mohamed AM; Refaat B; Idris S; Ahmad J
Drug Des Devel Ther; 2016; 10():2239-53. PubMed ID: 27468227
[TBL] [Abstract][Full Text] [Related]
24. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X
Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806
[TBL] [Abstract][Full Text] [Related]
25. Synergistic Role of Thymoquinone on Anticancer Activity of 5-Fluorouracil in Triple Negative Breast Cancer Cells.
Zheng M; Mei Z; Junaid M; Tania M; Fu J; Chen HC; Khan MA
Anticancer Agents Med Chem; 2022; 22(6):1111-1118. PubMed ID: 34170813
[TBL] [Abstract][Full Text] [Related]
26. Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways.
Gao Y; Xiao X; Zhang C; Yu W; Guo W; Zhang Z; Li Z; Feng X; Hao J; Zhang K; Xiao B; Chen M; Huang W; Xiong S; Wu X; Deng W
J Pineal Res; 2017 Mar; 62(2):. PubMed ID: 27865009
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-fluorouracil in PIK3CA mutant gastric cancer cells.
Bhattacharya B; Akram M; Balasubramanian I; Tam KK; Koh KX; Yee MQ; Soong R
Cancer Biol Ther; 2012 Jan; 13(1):34-42. PubMed ID: 22336586
[TBL] [Abstract][Full Text] [Related]
29. Berberine regulates the Notch1/PTEN/PI3K/AKT/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells.
Li G; Zhang C; Liang W; Zhang Y; Shen Y; Tian X
Pharm Biol; 2021 Dec; 59(1):21-30. PubMed ID: 33417512
[TBL] [Abstract][Full Text] [Related]
30. Diallyl Disulfide Induces Apoptosis and Autophagy in Human Osteosarcoma MG-63 Cells through the PI3K/Akt/mTOR Pathway.
Yue Z; Guan X; Chao R; Huang C; Li D; Yang P; Liu S; Hasegawa T; Guo J; Li M
Molecules; 2019 Jul; 24(14):. PubMed ID: 31340526
[TBL] [Abstract][Full Text] [Related]
31. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
Xia A; Li H; Li R; Lu L; Wu X
Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
[TBL] [Abstract][Full Text] [Related]
32. Autophagy participates in the protection role of 1,25-dihydroxyvitamin D3 in acute myocardial infarction via PI3K/AKT/mTOR pathway.
Wei YX; Dong SM; Wang YY; Zhang P; Sun MY; Wei YX; Meng XC; Wang Y
Cell Biol Int; 2021 Feb; 45(2):394-403. PubMed ID: 33146448
[TBL] [Abstract][Full Text] [Related]
33. The role of c2orf68 and PI3K/Akt/mTOR pathway in human colorectal cancer.
Wen X; Zhu J; Dong L; Chen Y
Med Oncol; 2014 Aug; 31(8):92. PubMed ID: 25023051
[TBL] [Abstract][Full Text] [Related]
34. Piperlongumine, a piper alkaloid targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer.
Kumar S; Agnihotri N
Biomed Pharmacother; 2019 Jan; 109():1462-1477. PubMed ID: 30551398
[TBL] [Abstract][Full Text] [Related]
35. Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness.
De P; Sun Y; Carlson JH; Friedman LS; Leyland-Jones BR; Dey N
Neoplasia; 2014 Jan; 16(1):43-72. PubMed ID: 24563619
[TBL] [Abstract][Full Text] [Related]
36. A novel quinazolinone chalcone derivative induces mitochondrial dependent apoptosis and inhibits PI3K/Akt/mTOR signaling pathway in human colon cancer HCT-116 cells.
Wani ZA; Guru SK; Rao AV; Sharma S; Mahajan G; Behl A; Kumar A; Sharma PR; Kamal A; Bhushan S; Mondhe DM
Food Chem Toxicol; 2016 Jan; 87():1-11. PubMed ID: 26615871
[TBL] [Abstract][Full Text] [Related]
37. Thymoquinone-induced reactive oxygen species causes apoptosis of chondrocytes via PI3K/Akt and p38kinase pathway.
Yu SM; Kim SJ
Exp Biol Med (Maywood); 2013 Jul; 238(7):811-20. PubMed ID: 23788172
[TBL] [Abstract][Full Text] [Related]
38. Thymoquinone inhibits the proliferation and invasion of esophageal cancer cells by disrupting the AKT/GSK-3β/Wnt signaling pathway via PTEN upregulation.
Ma J; Zhang Y; Deng H; Liu Y; Lei X; He P; Dong W
Phytother Res; 2020 Dec; 34(12):3388-3399. PubMed ID: 32901987
[TBL] [Abstract][Full Text] [Related]
39. TMEM97 knockdown inhibits 5-fluorouracil resistance by regulating epithelial-mesenchymal transition and ABC transporter expression via inactivating the Akt/mTOR pathway in 5-fluorouracil-resistant colorectal cancer cells.
Xu Y; Tang Y; Xu Q; He W
Chem Biol Drug Des; 2024 Feb; 103(2):e14490. PubMed ID: 38388887
[TBL] [Abstract][Full Text] [Related]
40. Multi-drug loaded micelles delivering chemotherapy and targeted therapies directed against HSP90 and the PI3K/AKT/mTOR pathway in prostate cancer.
Le B; Powers GL; Tam YT; Schumacher N; Malinowski RL; Steinke L; Kwon G; Marker PC
PLoS One; 2017; 12(3):e0174658. PubMed ID: 28350865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]